Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|April 16, 2025
Enhancing the Stability of <sup>211</sup>At Radiopharmaceuticals: Insights from Ortho-Substituent StrategiesTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Tetrahydrocyclohepteneindole Derivatives Targeting Estrogen Receptor Alpha for the Treatment of Breast CancerZhendong Song, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Multivalent FAPI-based radiopharmaceuticals in PET/CT: from cancer diagnostics to theranosticsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Tetrahydrobenzo[<i>b</i>]pyrazolo[3,4-<i>e</i>][1,4]diazepine Compounds as Oxytocin Receptor Agonists for Treating Autism Spectrum DisordersZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Sulfonamide Derivatives as Nav1.5 Sodium Channel Blockers for Treating Atrial FibrillationSiyan Feng, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating CancersJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson's DiseaseZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Peptides as GIPR/GLP-1R/GCGR Triagonists for Treating Type 2 Diabetes MellitusQilong Hu, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Piperazine Derivatives as Selective Antagonists of GluN2B-Containing NMDARs under Acidic pH ConditionsYinlong Li, Steven H Liang
Australian Journal of Chemistry|August 12, 2016
<i>Total Radiosynthesis</i>: Thinking outside "the box"Steven H Liang, Neil Vasdev
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|April 16, 2025
Enhancing the Stability of <sup>211</sup>At Radiopharmaceuticals: Insights from Ortho-Substituent StrategiesTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Tetrahydrocyclohepteneindole Derivatives Targeting Estrogen Receptor Alpha for the Treatment of Breast CancerZhendong Song, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Multivalent FAPI-based radiopharmaceuticals in PET/CT: from cancer diagnostics to theranosticsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Tetrahydrobenzo[<i>b</i>]pyrazolo[3,4-<i>e</i>][1,4]diazepine Compounds as Oxytocin Receptor Agonists for Treating Autism Spectrum DisordersZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Sulfonamide Derivatives as Nav1.5 Sodium Channel Blockers for Treating Atrial FibrillationSiyan Feng, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating CancersJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson's DiseaseZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Peptides as GIPR/GLP-1R/GCGR Triagonists for Treating Type 2 Diabetes MellitusQilong Hu, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Piperazine Derivatives as Selective Antagonists of GluN2B-Containing NMDARs under Acidic pH ConditionsYinlong Li, Steven H Liang
Australian Journal of Chemistry|August 12, 2016
<i>Total Radiosynthesis</i>: Thinking outside "the box"Steven H Liang, Neil Vasdev
Pageof 27